EF
MIRM icon

Empowered Funds’s Mirum Pharmaceuticals MIRM Stock Holding History

Empowered Funds’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$229K Buy
+1,959
New +$197K ﹤0.01% 1960
2025
Q2 		– Sell
-38,386
Closed -$1.73M – 1811
2025
Q1 		$1.73M Buy
38,386
+5,120
+15% +$241K 0.02% 814
2024
Q4 		$1.38M Buy
+33,266
New +$1.39M 0.02% 884

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Empowered Funds's MIRM Position: Q2 2026 in Review

Empowered Funds opened a new position in Mirum Pharmaceuticals (MIRM) in Q2 2026: 1,959 shares worth $229K. The stake represents ﹤0.01% of the portfolio and ranks #1960 among its holdings. This is a return to the name: Empowered Funds previously reported a position in MIRM as recently as Q1 2025.

Empowered Funds first reported a position in MIRM in Q4 2024 and has held it in 3 quarters since. The position peaked at $1.73M in Q1 2025. 328 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Empowered Funds held 1,959 shares of Mirum Pharmaceuticals worth $229K as of Q2 2026.
  • Mirum Pharmaceuticals was a new Empowered Funds position in Q2 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of Empowered Funds's portfolio in Q2 2026, its #1960 holding.
  • Empowered Funds first reported a position in Mirum Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • Empowered Funds's Mirum Pharmaceuticals position peaked at $1.73M in Q1 2025.
  • 328 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.